最新！　心臓デバイス攻略本

出版社： メディカ出版
著者：
発行日： 2023-02-01
分野： 臨床医学：内科  >  循環器一般
ISBN： 9784840481489
電子書籍版： 2023-02-01 （電子書籍版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：約3営業日

4,950 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,950 円(税込)

購入する

商品紹介

ペースメーカ・ICD治療の最前線について、適応、機能・特徴の要点を押さえて、わかりやすく解説する。適応のエビデンス、主要メーカー製のデバイスの機能・特徴比較一覧も付いているから、さっと学べて、ぐっと納得できる。初学者に必携の頼もしい一冊！

目次

  • 【第1章】ペースメーカ
    1　ペースメーカの適応疾患
    2　ペースメーカの基本（ICHDコード）
    3　ペースメーカの仕組み(1)
    4　ペースメーカの仕組み(2)
    5　ペースメーカの機能
    6　リードレスペースメーカ

    【第2章】ICD
    1　ICDのエビデンス
    2　ICDの仕組み(1)
    3　ICDの仕組み(2)
    4　ICDの機能
    5　ICDの設定方法
    6　皮下植込み型除細動器（S-ICD）・着用型自動除細動器（WCD）

    【第3章】CRT
    1　CRTの適応
    2　CRTの設定・機能

    【第4章】刺激伝導系ペーシング
    1　ヒス束ペーシング
    2　左脚領域ペーシング

    【第5章】植込み型心電計
    1　植込み型心電計の適応・機能
    2　植込み型心電計の実際

    【第6章】トラブルシューティング
    1　リード断線・損傷、磁場干渉などのトラブルシューティング
    2　ICD、デバイス感染などのトラブルシューティング

    【第7章】デバイス植込み術後の管理
    1　デバイス植込み術後の基本管理
    2　遠隔モニタリングの活用

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 ペースメーカ

P.13 掲載の参考文献
1) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 2022年改訂版 不整脈の診断とリスク評価に関するガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Takase.pdf
 
2) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン(2018年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2018/07/JCS2018_kurita_nogami.pdf
 
P.36 掲載の参考文献
1) 日本不整脈心電学会 植込み型心臓デバイス認定士制度部会編."デバイスの構造". 植込み型心臓デバイス認定士公式テキスト. 東京, 南江堂, 2021, 2-9.
 
2) 石川利之. "ペースメーカの基本:リード". 心臓ペーシングのすべて. 改訂3版. 東京, 中外医学社, 2022, 11-5.
 
3) Maisel WH, et al. Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines:developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association(AHA). Heart Rhythm. 6(6), 2009, 869-85.
 
4) 日本デバイス治療研究所."(4)ペースメーカ専用電池の登場", "(5)ペースメーカの電池とICDの電池の決定的な相違点". デバイス治療講座:工学講座. http://square.umin.ac.jp/J-RIDT/medical/engnrng.htm
 
5) Hudnall H. Reactive Atrial-based Antitachycardia Pacing Therapy to Slow Progression of Atrial Fibrillation. 2017, Medtronic data on file.
 
6) Chugh SS, et al. Worldwide epidemiology of atrial fibrillation:a global burden of disease 2010 study. Circulation. 129(8), 2014, 837-47.
PubMed
P.48 掲載の参考文献
1) Sweeney MO, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 107(23), 2003, 2932-7.
 
2) Sweeney MO, et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med. 357(10), 2007, 1000-8.
PubMed
P.58 掲載の参考文献
1) Lamas GA, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 346(24), 2002, 1854-62.
 
2) Boriani G, et al. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias:the MINERVA randomized multicentre international trial. Eur Heart J. 35(35), 2014, 2352-62.
 
P.70 掲載の参考文献
1) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 2021年JCS/JHRSガイドラインフォーカスアップデート版不整脈非薬物治療. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Kurita_Nogami.pdf
 
2) Kirkfeldt RE, et al. Complications after cardiac implantable electronic device implantations:an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 35(18), 2014, 1186-94.
PubMed
3) Cantillon DJ, et al. Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers. Heart Rhythm. 15(7), 2018, 1023-30.
PubMed
4) Steinwender C, et al. Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker:Results From the MARVEL 2 Study. JACC Clin Electrophysiol. 6(1), 2020, 94-106.
PubMed
5) Reynolds D, et al. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. 374(6), 2016, 533-41.
 
6) Roberts PR, et al. A leadless pacemaker in the real-world setting:The Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm. 14(9), 2017, 1375-9.
PubMed
7) Hauser RG, et al. Leadless pacemaker perforations:Clinical consequences and related device and user problems. J Cardiovasc Electrophysiol. 33(2), 2022, 154-9.
PubMed
8) 日本不整脈心電学会. リードレスペースメーカ植込み術に関する施設基準および資格要件. https://new.jhrs.or.jp/information-on-statements-standards-and-requirements/criteria/03a/
 
9) Noheria A, et al. Single-site ventricular pacing via the coronary sinus in patients with tricuspid valve disease. Europace. 20(4), 2018, 636-42.
PubMed
10) Glikson M, et al., ESC Scientific Document Group. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 42(35), 2021, 3427-520.
PubMed
11) Kerwin SA, et al. Transcatheter pacemaker implantation in a patient with a bioprosthetic tricuspid valve. J Interv Card Electrophysiol. 44(1), 2015, 89-90.
 
12) Boveda S, et al. Leadless pacemaker surrounded by three valvular prostheses. Heart Rhythm. 14(9), 2017, 1421.
PubMed
13) Mizuno A, et al. Usefulness of lewis lead for visualizing p-wave. Circ J. 78(11), 2014, 2774-5.
PubMed
14) Higuchi M, et al. Predictors of increase in pacing threshold after transcatheter pacing system implantation due to micro-dislodgement. Pacing Clin Electrophysiol. 43(11), 2020, 1351-7.
PubMed
15) Kiani S, et al. A Predictive Model for the Long-Term Electrical Performance of a Leadless Transcatheter Pacemaker. JACC Clin Electrophysiol. 7(4), 2021, 502-12.
 
16) Breeman KTN, et al. Long-term performance of a novel communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system:A comprehensive preclinical study. Heart Rhythm. 19(5), 2022, 837-46.
 
17) Reddy VY, et al. Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing:The SELECT-LV Study. J Am Coll Cardiol. 69(17), 2017, 2119-29.
PubMed

第2章 ICD

P.79 掲載の参考文献
1) Kastor JA. Michel Mirowski and the automatic implantable defibrillator. Am J Cardiol. 63(15), 1989, 1121-6.
PubMed
2) Mirowski M, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 303(6), 1980, 322-4.
PubMed
3) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン(2018年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2018/07/JCS2018_kurita_nogami.pdf
 
4) Poole JE, et al., Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 359(10), 2008, 1009-17. doi:10.1056/NEJMoa071098.
 
5) Wilkoff BL, et al., PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients:results from the PREPARE(Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 52(7), 2008, 541-50. doi:10.1016/j. jacc. 2008.05.011.
 
6) Moss AJ, et al., MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 367(24), 2012, 2275-83. doi:10.1056/NEJMoa1211107. Epub 2012 Nov 6.
 
7) Bardy GH, et al., Sudden Cardiac Death in Heart Failure Trial(SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 352(3), 2005, 225-37. doi:10.1056/NEJMoa043399. Erratum in:N Engl J Med. 352(20), 2005, 2146.
 
8) Kadish A, et al., Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation(DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 350(21), 2004, 2151-8. doi:10.1056/NEJMoa033088.
 
9) Greenberg H, et al., MADIT-II Investigators. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial(MADIT-II). J Am Coll Cardiol. 43(8), 2004, 1459-65. doi:10.1016/j. jacc. 2003.11.038. PMID:15093884.
 
10) Bristow MR, et al., Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION)Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 350(21), 2004, 2140-50. doi:10.1056/NEJMoa032423.
 
11) Buxton AE, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 342(26), 2000, 1937-45. doi:10.1056/NEJM200006293422602.
 
P.90 掲載の参考文献
1) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン(2018年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2018/07/JCS2018_kurita_nogami.pdf
 
2) 日本不整脈デバイス工業会. 2021年 植込み型除細動器(ICD)市場調査(植込みベース). https://www.jadia.or.jp/date/2021_icd.pdf
 
3) Weretka S, et al. Ventricular oversensing:a study of 101 patients implanted with dual chamber defibrillators and two different lead systems. Pacing Clin Electrophysiol. 26(1 Pt 1), 2003, 65-70.
 
4) 藤田禎規ほか. Integrated Bipolar ICD Leadの心房波オーバーセンシングによる失神. 心電図. 26(5), 2006, 737-43.
Medical*Online
5) 石川利之. "ペースメーカの基本:ペースメーカ本体;電池". 心臓ペーシングのすべて. 改訂3版. 東京, 中外医学社, 2022, 9-11.
 
6) Denman RA, et al. Benefit of millisecond waveform durations for patients with high defibrillation thresholds. Heart Rhythm. 3(5), 2006, 536-41.
PubMed
7) Kurt M, et al. Avoiding inappropriate therapy of single-lead implantable cardioverter-defibrillator by using atrial-sensing electrodes. J Cardiovasc Electrophysiol. 29(12), 2018, 1682-9.
PubMed
8) Hintringer F, et al. Comparison of the specificity of implantable dual chamber defibrillator detection algorithms. Pacing Clin Electrophysiol. 27(7), 2004, 976-82.
PubMed
9) 日本不整脈心電学会 植込み型心臓デバイス認定士制度部会編. "植込み手技:植込み手技の実際". 植込み型心臓デバイス認定士公式テキスト. 東京, 南江堂, 2021, 116-7.
 
P.111 掲載の参考文献
1) Poole JE, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 359(10), 2008, 1009-17.
PubMed
2) Sanders P, et al. Increased Hospitalizations and Overall Healthcare Utilization in Patients Receiving Implantable Cardioverter-Defibrillator Shocks Compared With Antitachycardia Pacing. JACC Clin Electrophysiol. 4(2), 2018, 243-53.
PubMed
3) Wathen MS, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation. 104(7), 2001, 796-801.
PubMed
4) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 2021年JCS/JHRSガイドライン フォーカスアップデート版 不整脈非薬物治療. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Kurita_Nogami.pdf
 
5) Hayashi K, et al. "Successful defibrillation by modifying from fixed-tilt to tuned-duration defibrillation waveform:When less is more?" Heart Rhythm Case Reports. https://doi.org/10.1016/j.hrcr.2022.07.019
 
P.118 掲載の参考文献
1) Poole JE, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 359(10), 2008, 1009-17.
PubMed
2) Mark DB, et al. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med. 359(10), 2008, 999-1008.
 
3) Moss AJ, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Eng J Med. 367(24), 2012, 2275-83.
 
4) Stiles MK, et al. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 17(1), 2020, e220-8.
PubMed
5) Gasparini M, et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery:the ADVANCE III randomized clinical trial. JAMA. 309(18), 2013, 1903-11.
PubMed
6) Wathen MS, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators:Pacing Fast Ventricular Tachycardia Reduces Shock Therapies(PainFREE Rx II) trial results. Circulation. 110(17), 2004, 2591-6.
PubMed
7) Gulizia MM, et al. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators:the PITAGORA ICD trial. Circ Arrhythm Electrophysiol. 2(2), 2009, 146-53.
PubMed
8) Gasparini M, et al. BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy:the ADVANCE CRT-D Trial. Am Heart J. 159(6), 2010, 1116-23. e2.
 
P.127 掲載の参考文献
1) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン(2018年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2018/07/JCS2018_kurita_nogami.pdf
 
2) Knops RE, et al. Subcutaneous or Transvenous Defibrillator Therapy. N Engl J Med. 383(6), 2020, 526-36.
 
3) Gold MR, et al. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction(UNTOUCHED) Trial. Circulation. 143(1), 2021, 7-17.
 
4) Bardy GH, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 352(3), 2005, 225-37.
 
5) Hohnloser SH, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 351(24), 2004, 2481-8.
PubMed
6) Solomon SD, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 352(25), 2005, 2581-8.
 
7) Olgin JE, et al. Wearable Cardioverter-Defibrillator after Myocardial Infarction. N Engl J Med. 379(13), 2018, 1205-15.
PubMed
8) Kishihara J, et al. An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting. J Arrhythm. 32(1), 2016, 67-9.
 

第3章 CRT

P.133 掲載の参考文献
1) Abraham WT, et al., MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 346(24), 2002, 1845-53.
 
2) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン(2018年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2018/07/JCS2018_kurita_nogami.pdf
 
3) Ghio S, et al. Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. Eur Heart J. 25(7), 2004, 571-8.
PubMed
4) Tang ASL, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 363(25), 2010, 2385-95.
PubMed
5) Moss AJ, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 361(14), 2009, 1329-38.
PubMed
P.138 掲載の参考文献
1) Mullens W, et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol. 53(9), 2009, 765-73.
 
2) White JA, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. 48(10), 2006, 1953-60.
PubMed
3) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン(2018年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2018/07/JCS2018_kurita_nogami.pdf
 
4) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 2021年JCS/JHRSガイドライン フォーカスアップデート版 不整脈非薬物治療. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Kurita_Nogami.pdf.
 
5) Singh JP, et al. Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. Heart Rhythm. 3(11), 2006, 1285-92.
PubMed
6) Brignole M, et al., APAF-CRT Trial Investigators. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS:the APAF-CRT mortality trial. Eur Heart J. 42(46), 2021, 4731-9.
PubMed
7) Marrouche NF, et al., CASTLE-AF Investigators. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med. 378(5), 2018, 417-27.
PubMed
8) McIntyre L, et al. Blood component transfusion in critically ill patients. Curr Opin Crit Care. 19(4), 2013, 326-33.
 

第4章 刺激伝導系ペーシング

P.144 掲載の参考文献
1) 岡田了三. 刺激生成伝導系の形態. 心臓. 5(6), 1973, 853-67.
 
2) Khurshid S, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm. 11(9), 2014, 1619-25.
PubMed
3) Sharma PS, et al. Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice. Heart Rhythm. 12(2), 2015, 305-12.
PubMed
4) Abdelrahman M, et al. Clinical outcomes of His bundle pacing compared to right ventricular pacing. J Am Coll Cardiol. 71(20), 2018, 2319-30.
PubMed
5) Beer D, et al. Clinical Outcomes of Selective Versus Nonselective His Bundle Pacing. JACC Clin Electrophysiol. 5(7), 2019, 766-74.
PubMed
6) Sato T, et al. Safety of distal His bundle pacing via the right ventricle backed up by adjacent ventricular capture. JACC Clin Electrophysiol. 7(4), 2021, 513-21.
PubMed
7) Vijayaraman P, et al. Permanent His-bundle pacing:Long-term lead performance and clinical outcomes. Heart Rhythm. 15(5), 2018, 696-702.
PubMed
P.152 掲載の参考文献
1) Sharma PS, et al. Clinical outcomes of left bundle branch area pacing compared to right ventricular pacing:Results from the Geisinger-Rush Conduction System Pacing Registry. Heart Rhythm. 19(1), 2022, 3-11.
 
2) Vijayaraman P, et al. Clinical outcomes of left bundle branch area pacing compared to His bundle pacing. J Cardiovasc Electrophysiol. 33(6), 2022, 1234-43.
PubMed
3) Ponnusamy SS, et al. Electrophysiological characteristics of septal perforation during left bundle branch pacing. Heart Rhythm. 19(5), 2022, 728-34.
 
4) Ravi V, et al. Late-onset interventricular septal perforation from left bundle branch pacing. Heart Rhythm Case Rep. 6(9), 2020, 627-31.
 

第5章 植込み型心電計

P.160 掲載の参考文献
1) Giancaterino S, et al. Current and Future Use of Insertable Cardiac Monitors. JACC Clin Electrophysiol. 4(11), 2018, 1383-96.
PubMed
2) Sanna T, et al., CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 370(26), 2014, 2478-86.
PubMed
3) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン(2018年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2018/07/JCS2018_kurita_nogami.pdf
 

第6章 トラブルシューティング

P.176 掲載の参考文献
1) Providencia R, et al. Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance:A Meta-Analysis of Observational Studies. J Am Heart Assoc. 4(11), 2015, doi:10.1161/JAHA. 115.002418.
 
2) 日本不整脈デバイス工業会. ペースメーカ, ICDをご使用のみなさまへ. https://www.jadia.or.jp/images/poster/wide/2013.pdf
 
P.181 掲載の参考文献
1) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン(2018年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2018/07/JCS2018_kurita_nogami.pdf
 
2) Neugebauer F, et al. Leadless atrioventricular synchronous pacing in an outpatient setting:Early lessons learned on factors affecting atrioventricular synchrony. Heart Rhythm. 19(5), 2022, 748-56.
 
3) Steinwender C, et al. Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker:Results From the MARVEL 2 Study. JACC Clin Electrophysiol. 6(1), 2020, 94-106.
PubMed

第7章 デバイス植込み術後の管理

P.189 掲載の参考文献
1) Stiles MK, et al. 2019 HRS/HRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 17(1), 2020, E220-8.
 
2) Moss AJ, et al., MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 367(24), 2012, 2275-83.
PubMed
3) Wathen MS, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators:Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. 110(17), 2004, 2591-6.
PubMed
4) Leclercq C, et al. Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study:results from Phase I. Eur Heart J. 40(35), 2019, 2979-87.
PubMed
P.195 掲載の参考文献
1) 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン(2018年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2018/07/JCS2018_kurita_nogami.pdf
 
2) Watanabe E, et al. Remote Management of Pacemaker Patients With Biennial In-Clinic Evaluation:Continuous Home Monitoring in the Japanese At-Home Study:A Randomized Clinical Trial. Circ Arrhythm Electrophysiol. 13(5), 2020, e007734.
PubMed
3) Varma N, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up:the Lumos-T Safely Reduces Routine Office Device Follow-up(TRUST) trial. Circulation. 122(4), 2010, 325-32.
PubMed
4) Hindricks G, et al. Daily remote monitoring of implantable cardioverter-defibrillators:insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST). Eur Heart J. 38(22), 2017, 1749-55.
PubMed

書評

最近チェックした商品履歴

Loading...